Qiming Venture Partners has led a $37 million Series B round for Insilico Medicine, a Hong Kong-based drug development company that uses artificial intelligence (AI).
Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Eight Roads, F-Prime Capital, Pavilion Capital, and Bold Capital Partners also contributed. Previous investors include Hong Kong’s Deep Knowledge...
China's Reworld has a technology that lowers barriers to entry in online game design, allowing anyone to become a creator. Joy Capital is backing the company to take user-generated content to another level
Pop Mart International Group, China’s largest fashion toy retailer, has filed for a Hong Kong IPO. Sequoia Capital China, Loyal Valley Capital and Huaxing Growth Fund are its three largest institutional backers.
PLMP Venture Capital (PLMP VC), an investor affiliated with a Singaporean financial technology firm, has launched a local exchange for small and medium-sized enterprises (SMEs) in Cambodia.
Indian venture capital player Iron Pillar Capital Management has brought in US-headquartered real estate investment firm Nitya Capital as a strategic investor.